TNXP: No AdCom Required for TNX-102 SL NDA…
TNXP READ THE FULL TNXP RESEARCH REPORT Business Update No Advisory Committee Meeting for TNX-102 SL NDA On March 24, 2025, ...
Biomednewsbreaks - Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) Advances Non-Opioid Fibromyalgia Drug Toward FDA Decision
Tonix Pharmaceuticals (NASDAQ: TNXP) is gaining attention as it advances TNX-102 SL, a non-opioid investigational therapy for fibromyalgia, toward po ...
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
Detailed price information for Tonix Pharm Holdings (TNXP-Q) from The Globe and Mail including charting and trades.
Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference
Investors interested in arranging a meeting with the Company’s management during the conference should contact the Jones Trading conference coordinator. A live webcast of the presentation can be found ...
Investornewsbreaks Tonix Pharmaceuticals Holding Corp. (NASDAQ: TNXP) CEO To Present At 2025 Jones Trading Healthcare Conference
Tonix Pharmaceuticals (NASDAQ: TNXP) , a fully integrated biopharmaceutical company with marketed products and a robust development pipeline, announc ...
American Association of Individual Investors3d
Why Tonix Pharmaceuticals Holding Corp.’s (TNXP) Stock Is Down 11.27%
Tonix Pharmaceuticals Holding Corp.’s TNXP share price has dipped by 11.27%, which has investors questioning if this is right time to buy.
Seeking Alpha4d
Tonix’s Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
Their drug TNX-102 SL* (cyclobenzaprine HCl sublingual tablets), a non-opioid investigational drug targeting fibromyalgia, which affects millions of Americans, mostly women. This type of pain ...
Investing3d
Tonix Pharmaceuticals launches migraine management platform
Tonix Pharmaceuticals, known for its focus on central nervous system disorders and pain management, is also advancing TNX-102 SL, a product candidate for fibromyalgia management, with a PDUFA goal ...
Finanznachrichten4d
Tonix Pharmaceuticals Holding: Tonix's Experimental Non-Opioid Analgesic Treatment for Fibromyalgia Could Start Bringing Relief Later This Year
Their drug TNX-102 SL* (cyclobenzaprine HCl sublingual tablets), a non-opioid investigational drug targeting fibromyalgia, which affects millions of Americans, mostly women. This type of pain ...